| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 07/19/2007 | US20070167449 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | CA2631360A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 07/18/2007 | EP1808464A1 Filter for electronic display |
| 07/18/2007 | EP1807417A2 Pyrazolylmethyl heteroaryl derivatives |
| 07/18/2007 | EP1807393A1 Diarylsulfones as 5-ht2a antagonists |
| 07/18/2007 | EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN101001842A Amido compounds and their use as pharmaceuticals |
| 07/18/2007 | CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor |
| 07/17/2007 | US7244851 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies |
| 07/17/2007 | US7244757 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/12/2007 | WO2007079086A1 Pyrazoloalkyl substituted imidazo ring compounds and methods |
| 07/12/2007 | WO2007056091A3 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof |
| 07/12/2007 | WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof |
| 07/12/2007 | WO2007021873A3 Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof |
| 07/12/2007 | WO2007017628A3 Process for printing an image, composition and compound |
| 07/12/2007 | WO2006036498A3 A process for the preparation of 1,3,5-trisubstituted pyrazoles via [3+2] cycloaddition |
| 07/12/2007 | WO2006029075A3 Fibrate compounds having ppar agonist activity |
| 07/12/2007 | US20070161790 Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161626 Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof |
| 07/12/2007 | US20070161026 Regents labeled with energy transfer dyes |
| 07/11/2007 | EP1805145A1 Process for the preparation of pyrazoles |
| 07/11/2007 | CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 07/11/2007 | CN1997363A Resistance-repellent retroviral protease inhibitors |
| 07/11/2007 | CN1995021A Pyrazole derivatives production process |
| 07/10/2007 | US7241794 Nonnucleoside reverse transcriptase inhibitors |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241792 For therapy of dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like |
| 07/10/2007 | US7241791 Substituted 4-(indazol-3-yl)phenols |
| 07/10/2007 | US7241783 Using a thiosemicarbazone |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity |
| 07/10/2007 | CA2276463C Substituted 4-benzoyl-pyrazoles |
| 07/05/2007 | WO2007075847A2 Glucokinase activators |
| 07/05/2007 | WO2007074632A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP |
| 07/05/2007 | WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof |
| 07/05/2007 | US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist |
| 07/05/2007 | US20070155812 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155777 Antiinflammation agents |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155748 N-sulfonyl-alpha-amino-acid derivatives |
| 07/05/2007 | US20070155735 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155728 Substituted Heterocyclic Compounds |
| 07/05/2007 | US20070154927 Energy transfer dyes with enhanced fluorescence |
| 07/05/2007 | US20070154924 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing |
| 07/05/2007 | CA2633584A1 Glucokinase activators |
| 07/04/2007 | EP1802600A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonits for the treatment of urological disorders |
| 07/04/2007 | EP1802582A1 Benzamide derivatives that act upon the glucokinase enzyme. |
| 07/04/2007 | EP1802570A1 Process for making phenoxy benzamide compounds |
| 07/04/2007 | CN1993321A 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 07/04/2007 | CN1993316A Catalytic methods for the production of (meth)acrylates from n-hydroxyalkylated amides |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/03/2007 | US7238722 Pyrazolylalkines |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238696 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 07/03/2007 | CA2359092C Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods |
| 06/28/2007 | WO2007073405A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 06/28/2007 | WO2007073297A1 Pyrazoles for the treatment of gerd and ibs |
| 06/28/2007 | WO2007071900A1 Novel herbicides |
| 06/28/2007 | WO2007071766A2 Phenoxy acetic acids as ppar delta activators |
| 06/28/2007 | WO2007071662A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | WO2007015999A3 Process for synthesizing a substituted pyrazole |
| 06/28/2007 | WO2006123088A3 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides |
| 06/28/2007 | US20070149780 Process for preparing haloalkyl(thio)vinimidinium salts and 4-(haloalkyl(thio))pyrazoles and their conversion to crop protection compositions |
| 06/28/2007 | US20070149603 Ppar active compounds |
| 06/28/2007 | US20070149592 Targeting gli proteins in human cancer by small molecules |
| 06/28/2007 | US20070149575 5-Aminoalkylpyrazole derivatives as pesticidal agents |
| 06/28/2007 | US20070149571 Combination therapy for treating or managing acute myelocytic leukemia |
| 06/28/2007 | US20070149549 Prenylation Inhibitors and Methods of Their Synthesis and Use |
| 06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 06/28/2007 | US20070149406 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives |
| 06/28/2007 | US20070148217 Percutaneous absorption type cerebral protective agent |
| 06/28/2007 | DE102005060466A1 Carboxamide Carboxamides |
| 06/28/2007 | CA2669503A1 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 06/28/2007 | CA2634699A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 06/28/2007 | CA2632582A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | CA2632011A1 Pyrazoles for the treatment of gerd and ibs |
| 06/28/2007 | CA2631390A1 Phenoxy acetic acids as ppar delta activators |
| 06/28/2007 | CA2631145A1 Novel herbicides |
| 06/27/2007 | EP1800118A1 Agent and method for identifying furfurals |
| 06/27/2007 | EP1799673A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 06/27/2007 | EP1799658A2 Modulators of crth2 rezeptor activity for the treatment of prostaglandin d2 mediated diseases |
| 06/27/2007 | EP1799649A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 06/27/2007 | EP1799213A2 Novel curcumin analogues and uses thereof |
| 06/27/2007 | EP1799208A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/27/2007 | EP1799206A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides |
| 06/27/2007 | CN1988903A Ophthalmic compositions for treating ocular hypertension |
| 06/27/2007 | CN1986532A Organic acid salt of N-piperidyl-1-(2,4-dichlorophenyl)-4-methyl-5-(4-chlorophenyl)-pyrazolyl-3-formamide and its preparing method |
| 06/26/2007 | USRE39708 Estrogen receptor modulators |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |